As expected, the combination of both RNF43 and CD163 with TNM stage gained the highest accuracy for OS and PFS of ccRCC patients, compared with that of any other indicators alone (Figure 3; Table 3). The gene discussed is CD163; the disease is nonpapillary renal cell carcinoma.